These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 20236340)

  • 1. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial.
    MacGregor EA; Victor TW; Hu X; Xiang Q; Puenpatom RA; Chen W; Campbell JC
    Headache; 2010 Apr; 50(4):528-38. PubMed ID: 20236340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
    Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
    Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective comparison between ICHD-II and probability menstrual migraine diagnostic criteria.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):539-50. PubMed ID: 20236338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.
    Silberstein SD; Massiou H; McCarroll KA; Lines CR
    Headache; 2002 Oct; 42(9):917-23. PubMed ID: 12390621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
    Mannix LK; Loder E; Nett R; Mueller L; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
    Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.
    Granella F; Sances G; Allais G; Nappi RE; Tirelli A; Benedetto C; Brundu B; Facchinetti F; Nappi G
    Cephalalgia; 2004 Sep; 24(9):707-16. PubMed ID: 15315526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study.
    Newman LC; Harper S; Jones BA; Campbell J
    J Womens Health (Larchmt); 2009 Aug; 18(8):1265-73. PubMed ID: 19627225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics: the menstrual migraine assessment tool.
    Tepper SJ; Zatochill M; Szeto M; Sheftell F; Tepper DE; Bigal M
    Headache; 2008; 48(10):1419-25. PubMed ID: 19076645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rizatriptan in the treatment of menstrual migraine.
    Silberstein SD; Massiou H; Le Jeunne C; Johnson-Pratt L; McCarroll KA; Lines CR
    Obstet Gynecol; 2000 Aug; 96(2):237-42. PubMed ID: 10908770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.